BioDlink Named "Emerging CDMO of the Year" at the 2026 Asia-Pacific Biopharma Excellence Awards
BioDlink has been named "Emerging CDMO of the Year" for its innovation in complex biologics and ADC development. The award recognizes its proprietary technology platforms, scalable manufacturing, and a proven quality system with over 100 audits...
MOVA Unveils the "Infinite Smart Universe" at AWE, Presenting the Vision of All-Scenario Smart Living
SHANGHAI, March 13, 2026 /PRNewswire/ -- After its stunning debut at AWE last year, global premium smart technology brand MOVA is set to make a strong return in 2026 with significant technological and brand evolution. This year, MOVA's exhibition...
Xinhua Silk Road: 34th East China Fair highlights resilience and vitality in foreign trade
BEIJING, March 13, 2026 /PRNewswire/ -- When the four-day 34th East China Fair (ECF) concluded in Shanghai recently, its bumper harvest of about 2.2 billion U.S. dollars of intent orders attested again to the vitality and resilience of China's...
World's First Self-Balancing Motorcycle OMO X Enters Mass Production: A New Era for Smart Two-Wheelers
SINGAPORE, March 13, 2026 /PRNewswire/ -- At the 2026 Global Technology Launch held at Jewel Changi Airport's Canopy Park, OMOWAY announced that its flagship self-balancing electric motorcycle, the OMO X, has officially entered mass production, with...
Ferretti Board Recommends Against KKCG Partial Offer
This is a report from the Shandong Office of Hong Kong Business Daily. Ferretti S.p.A. has recommended shareholders reject KKCG's voluntary conditional partial offer. Its Independent Financial Adviser concluded that the €3.50 per share offer is "not...
ThunderSoft Showcases Edge AI Innovations at embedded world 2026, Highlighting the Rise of Intelligent Edge Systems
NUREMBERG, Germany, March 13, 2026 /PRNewswire/ -- As embedded world 2026 concludes in Nuremberg, one theme stands out across the exhibition halls: the rapid acceleration of intelligent edge systems. With the convergence of high-performance...
Unixell Biotech receives IND clearance by FDA for its Allogeneic iPSC-Derived cell therapy, UX-GIP001, for focal Epilepsy
SHANGHAI, March 13, 2026 /PRNewswire/ -- On March 12, Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational New Drug (IND) clearance from the U.S....
XtalPi Holdings Limited to Announce 2025 Annual Results on March 25, 2026
CAMBRIDGE, Mass., March 13, 2026 /PRNewswire/ -- XtalPi Holdings Limited ("XtalPi", or the "Company") (HKEX: 2228), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery,...